home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Digital Health and Digital Technologies Congress

 
  February 07, 2018  
     
 
Oxford Global Conferences, London
25-26 September 2018


Join Oxford Global for the Digital Health and Digital Technologies Congress, 25-26 September 2018, London where over 250 attendees will be representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Across two days, we will bring together 18 presentations and case studies focusing on the key developments in digital health and digital therapeutics looking at critical areas such as digital health regulations, patient engagement, wearable technologies, digital therapeutic technologies and optimising real-time technology in clinical trials.

Including 2 interactive streams:

  • Digital Health Strategies
  • Designing and Developing Digital Therapies
 
 
Organized by: Oxford Global
Invited Speakers:

2017 Confirmed Pharmatec Series Speakers Included:

Pharmaceutical IT Congress;

Philip Hajduk, Vice President, R&D Information Research
AbbVie

Emmanuel Pham, Vice President Biometry
Ipsen Innovation

Sandy Farmer, Executive Director, Genome Sciences & Technologies
Pfizer

Margaret McDonald, Senior Director, Real World Data and Analytics
Pfizer Inc.

Claus Bendtsen, Executive Director
AstraZeneca

Christine Buesnel, Director, Product Development, Biometrics
Genentech

Lars Greiffenberg, Director R&D Information Research, Translational Informatics & AbbVie Library
AbbVie

Oliver Hesse, Director Lab Automation & Data Management
Bayer

Nigel Hughes, Scientific Director
Janssen Pharma R&D

Raphaël Pousset-Bougère, Big Data & Analytics Vice-President
Ipsen

Chad Dau, Global Head of RWI Infrastructure and Regional Services
Astellas

Etzard Stolte, Global Head Knowledge Management PTD
Hoffmann La Roche

Hugo Ceulemans, Scientific Director Discovery Data Sciences
Janssen

Alaa Hamed, Rare Disease Business Partner, Health Economics and Value Assessment
Sanofi Genzyme

Jan Hauβ, Head of R&D LIMS
Merck KGaA

Alexander Krupp, Head of Computational LifeScience IT
Bayer

Richardus Vonk, Head of Medical Writing and Statistics Oncology
Bayer AG

Gerhard Noelken, Business Development Europe
Pistoia Alliance, Inc.

Angeli Möller, IT Business Partner for Clinical Sciences
Bayer AG

Andrew Garrood, Service Delivery Manager, End User Computing Client Devices
Novartis A.G

Francis Kendall, Technology and Evaluation Leader
Roche

Henning Kayser, Scientific Development IT
Bayer

Justin Lee, Senior Principal Data Scientist, Translational Informatics
Sanofi

Paul-Michael Agapow, Head Of Translational Bioinformatics, Data Science Institute
Imperial College London

Michael R. Barnes, Reader and Director of Bioinformatics
Queen Mary University of London

Timo Minssen, Professor of Life Science & Biotechnology Law
University of Copenhagen

2017 Solution Provider Speakers Include:

Mark Demesmaeker, Global Vice President, Scientific Analytics
PerkinElmer Informatics Inc.

Kees van Bochove, Chief Executive Officer
The Hyve

Misha Kapushesky, Chief Executive Officer
Genestack

Staffan Gestrelius, Founder and Chairman of the Board
Capish

Eddy Vande Water, Senior Director, BIOVIA Field Applications
Dassault Systèmes

Evjatar Cohen, Vice President Global Pharmaceuticals and Life Sciences
Appian

Henry Levy, President
Align Biopharma

Artificial Intelligence Congress Speakers;

James Weatherall, Executive Director and Head of Advanced Analytics Centre
AstraZeneca

Hugo Ceulemans, Scientific Director Discovery Data Sciences
Janssen

Andrea Splendiani, Associate Director, Information Systems
Novartis

David Ohlssen, Head of Advanced Exploratory Analytics
Novartis

Kevin Hua, Senior Manager A.I./Machine Learning Development
Bayer LifeScience iHub

Jackie Hunter, Chief Executive Officer
Benevolent Bio

Ed Addison, Chairman and Chief Executive Officer
Cloud Pharmaceuticals

Jinhan Kim, Chief Executive Officer and Co-founder
Standigm

Krzysztof Potempa, Chief Executive Officer
BRAINCURES

Berton Earnshaw, Director, Data Science Research
Recursion Pharmaceuticals

Leonardo Rodrigues, Associate Director, Advanced Analytics
Berg Healthcare

Enrico Ferrero, Scientific Leader, Computational Biology
GlaxoSmithKline

Lars Carlsson, Team Leader and Principal Information Scientist
AstraZeneca

Rafael Depetris, Principal Scientist I
Kadmon Corporation

Alvaro Cortes, Computational Chemist
GlaxoSmithKline

Alex Gammerman, Professor of Computer Science, Royal Holloway
University of London

 
Deadline for Abstracts: 2018-09-25
 
Registration:

View Agenda: http://bit.ly/2E9DeOX   

For further information regarding prices and possible discounts, please contact Angela Fernandez on a.fernandez@oxfordglobal.co.uk or call +44 (0)1865 248 455.

E-mail: a.fernandez@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.